Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease

P (Hemachandra) Reddy

    Research output: Contribution to journalArticle

    266 Citations (Scopus)

    Abstract

    Alzheimer's disease (AD) is a late-onset dementia that is characterized by the loss of memory and an impairment of multiple cognitive functions. Advancements in molecular, cellular, and animal model studies have revealed that the formation of amyloid beta (Aβ) and other derivatives of the amyloid precursor protein (APP) are key factors in cellular changes in the AD brain, including the generation of free radicals, oxidative damage, and inflammation. Recent molecular, cellular, and gene expression studies have revealed that Aβ enters mitochondria, induces the generation of free radicals, and leads to oxidative damage in post-mortem brain neurons from AD patients and in brain neurons from cell models and transgenic mouse models of AD. In the last three decades, tremendous progress has been made in mitochondrial research and has provided significant findings to link mitochondrial oxidative damage and neurodegenerative diseases such as AD. Researchers in the AD field are beginning to recognize the possible involvement of a mutant APP and its derivatives in causing mitochondrial oxidative damage in AD. This article summarizes the latest research findings on the generation of free radicals in mitochondria and provides a possible model that links Aβ proteins, the generation of free radicals, and oxidative damage in AD development and progression.

    Original languageEnglish (US)
    Pages (from-to)1-13
    Number of pages13
    JournalJournal of Neurochemistry
    Volume96
    Issue number1
    DOIs
    StatePublished - Jan 2006

    Fingerprint

    Amyloid beta-Protein Precursor
    Free Radicals
    Alzheimer Disease
    Brain
    Mitochondria
    Amyloid
    Neurons
    Neurodegenerative diseases
    Derivatives
    Molecular Models
    Memory Disorders
    Mutant Proteins
    Research
    Gene expression
    Neurodegenerative Diseases
    Cognition
    Transgenic Mice
    Dementia
    Disease Progression
    Animals

    Keywords

    • In vitro studies
    • Mitochondria
    • Mitochondrial gene expression
    • Oxidative damage
    • Reactive oxygen species
    • Transgenic mice

    ASJC Scopus subject areas

    • Biochemistry
    • Cellular and Molecular Neuroscience

    Cite this

    Amyloid precursor protein-mediated free radicals and oxidative damage : Implications for the development and progression of Alzheimer's disease. / Reddy, P (Hemachandra).

    In: Journal of Neurochemistry, Vol. 96, No. 1, 01.2006, p. 1-13.

    Research output: Contribution to journalArticle

    @article{4617189e0cc14a548054b9e556ae38ae,
    title = "Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease",
    abstract = "Alzheimer's disease (AD) is a late-onset dementia that is characterized by the loss of memory and an impairment of multiple cognitive functions. Advancements in molecular, cellular, and animal model studies have revealed that the formation of amyloid beta (Aβ) and other derivatives of the amyloid precursor protein (APP) are key factors in cellular changes in the AD brain, including the generation of free radicals, oxidative damage, and inflammation. Recent molecular, cellular, and gene expression studies have revealed that Aβ enters mitochondria, induces the generation of free radicals, and leads to oxidative damage in post-mortem brain neurons from AD patients and in brain neurons from cell models and transgenic mouse models of AD. In the last three decades, tremendous progress has been made in mitochondrial research and has provided significant findings to link mitochondrial oxidative damage and neurodegenerative diseases such as AD. Researchers in the AD field are beginning to recognize the possible involvement of a mutant APP and its derivatives in causing mitochondrial oxidative damage in AD. This article summarizes the latest research findings on the generation of free radicals in mitochondria and provides a possible model that links Aβ proteins, the generation of free radicals, and oxidative damage in AD development and progression.",
    keywords = "In vitro studies, Mitochondria, Mitochondrial gene expression, Oxidative damage, Reactive oxygen species, Transgenic mice",
    author = "Reddy, {P (Hemachandra)}",
    year = "2006",
    month = "1",
    doi = "10.1111/j.1471-4159.2005.03530.x",
    language = "English (US)",
    volume = "96",
    pages = "1--13",
    journal = "Journal of Neurochemistry",
    issn = "0022-3042",
    publisher = "Wiley-Blackwell",
    number = "1",

    }

    TY - JOUR

    T1 - Amyloid precursor protein-mediated free radicals and oxidative damage

    T2 - Implications for the development and progression of Alzheimer's disease

    AU - Reddy, P (Hemachandra)

    PY - 2006/1

    Y1 - 2006/1

    N2 - Alzheimer's disease (AD) is a late-onset dementia that is characterized by the loss of memory and an impairment of multiple cognitive functions. Advancements in molecular, cellular, and animal model studies have revealed that the formation of amyloid beta (Aβ) and other derivatives of the amyloid precursor protein (APP) are key factors in cellular changes in the AD brain, including the generation of free radicals, oxidative damage, and inflammation. Recent molecular, cellular, and gene expression studies have revealed that Aβ enters mitochondria, induces the generation of free radicals, and leads to oxidative damage in post-mortem brain neurons from AD patients and in brain neurons from cell models and transgenic mouse models of AD. In the last three decades, tremendous progress has been made in mitochondrial research and has provided significant findings to link mitochondrial oxidative damage and neurodegenerative diseases such as AD. Researchers in the AD field are beginning to recognize the possible involvement of a mutant APP and its derivatives in causing mitochondrial oxidative damage in AD. This article summarizes the latest research findings on the generation of free radicals in mitochondria and provides a possible model that links Aβ proteins, the generation of free radicals, and oxidative damage in AD development and progression.

    AB - Alzheimer's disease (AD) is a late-onset dementia that is characterized by the loss of memory and an impairment of multiple cognitive functions. Advancements in molecular, cellular, and animal model studies have revealed that the formation of amyloid beta (Aβ) and other derivatives of the amyloid precursor protein (APP) are key factors in cellular changes in the AD brain, including the generation of free radicals, oxidative damage, and inflammation. Recent molecular, cellular, and gene expression studies have revealed that Aβ enters mitochondria, induces the generation of free radicals, and leads to oxidative damage in post-mortem brain neurons from AD patients and in brain neurons from cell models and transgenic mouse models of AD. In the last three decades, tremendous progress has been made in mitochondrial research and has provided significant findings to link mitochondrial oxidative damage and neurodegenerative diseases such as AD. Researchers in the AD field are beginning to recognize the possible involvement of a mutant APP and its derivatives in causing mitochondrial oxidative damage in AD. This article summarizes the latest research findings on the generation of free radicals in mitochondria and provides a possible model that links Aβ proteins, the generation of free radicals, and oxidative damage in AD development and progression.

    KW - In vitro studies

    KW - Mitochondria

    KW - Mitochondrial gene expression

    KW - Oxidative damage

    KW - Reactive oxygen species

    KW - Transgenic mice

    UR - http://www.scopus.com/inward/record.url?scp=33644845279&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33644845279&partnerID=8YFLogxK

    U2 - 10.1111/j.1471-4159.2005.03530.x

    DO - 10.1111/j.1471-4159.2005.03530.x

    M3 - Article

    C2 - 16305625

    AN - SCOPUS:33644845279

    VL - 96

    SP - 1

    EP - 13

    JO - Journal of Neurochemistry

    JF - Journal of Neurochemistry

    SN - 0022-3042

    IS - 1

    ER -